Inventor
BERLINER DAVID L
US33 patents
⚠️ This page may combine multiple inventors who share the name “BERLINER DAVID L”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
PHERIN CORP
16 patentsUS6066627AMay 23, 2000
Steroids as neurochemical initiators of change in human blood levels of LH
PHERIN CORP22 citations92
US5563131AOct 8, 1996
Pregnane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods
PHERIN CORP36 citations92
US6057439AMay 2, 2000
Steroids as neurochemical stimulators of the VNO to alleviate symptoms of PMS and anxiety
PHERIN CORP29 citations91
US5883087AMar 16, 1999
Androstane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods
PHERIN CORP18 citations91
US6432938B1Aug 13, 2002
19-nor-cholane steroids as neurochemical initators of change in human hypothalamic function
PHERIN CORP13 citations73
US5962443AOct 5, 1999
19-nur-pregnane steroids as neurochemical initiators of change in human hypothalamic function
PHERIN CORP7 citations73
US5925774AJul 20, 1999
Estrenes for inducing hypothalamic effects
PHERIN CORP5 citations73
US6140316AOct 31, 2000
Estrene steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions
PHERIN CORP14 citations72
US5994333ANov 30, 1999
Pregnane and cholane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods
PHERIN CORP7 citations72
US6437156B1Aug 20, 2002
19-nor-cholane steroids as neurochemical initiators of change in human hypothalamic function
PHERIN CORP4 citations62
US5994568ANov 30, 1999
Estrenes for inducing hypothalamic effects
PHERIN CORP1 citations62
US5969168AOct 19, 1999
Androstanes for inducing hypothalamic effects
PHERIN CORP3 citations62
US5939570AAug 17, 1999
Estrenes for inducing hypothalamic effects
PHERIN CORP1 citations62
US5922699AJul 13, 1999
19-nor-cholane steroids as neurochemical initiators of change in human hypothalamic function
PHERIN CORP4 citations62
US5633392AMay 27, 1997
Estrenes for inducing hypothalamic effects
PHERIN CORP5 citations62
US5783571AJul 21, 1998
Method of altering hypothalamic function by nasal administration of estrene steroids
PHERIN CORP6 citations61
PHERIN PHARM INC
8 patentsUS6117860ASep 12, 2000
Steroids as neurochemical stimulators of the VNO to treat paroxistic tachycardia
PHERIN PHARM INC23 citations91
US6331534B1Dec 18, 2001
Steroids as neurochemical stimulators of the VNO to alleviate pain
PHERIN PHARM INC30 citations90
US6544971B1Apr 8, 2003
Method of increasing alertness by administration of a vomeropherin, and vomeropherin-emitting alarm devices
PHERIN PHARM INC13 citations82
US6352980B1Mar 5, 2002
Estrenes for inducting hypothalamic effects
PHERIN PHARM INC5 citations73
US6242619B1Jun 5, 2001
19-norpregnane steroids as neurochemical initiators of change in human hypothalamic function
PHERIN PHARM INC7 citations73
US5965552AOct 12, 1999
Androstane steroids as neurochemical initators of change in human hypothalamic compositions and methods
PHERIN PHARM INC11 citations72
US6555531B1Apr 29, 2003
Weight promoting composition, method, and product
PHERIN PHARM INC0 citations50
US7087430B2Aug 8, 2006
Human VNO cDNA libraries
PHERIN PHARM INC0 citations42